CHG LSE Week ended 07 Aug 2026

Weekly Investor Report

Chemring Group PLC · Industrials · Aerospace & Defense

Latest close 627.0 GBP
6.2% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 18.2% above the Trend Line and sits at 91.4% of its 52-week range. The latest completed week returned 6.2%, after a 16.7% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is expensive relative to peers. The latest news-sentiment score is 55/100. Near-term considerations: price is close to its 52-week high.

Setup score 69 out of 100
Latest Close 627.0 GBP 7 Aug 2026
1W Return 6.2% latest completed week
4W Return 16.7% short-term follow-through
12W Return 35.0% quarterly tape
Trend Breadth 48.1% 25 of 52 weeks active
Volume Ratio 1.7x vs 13-week average
What is working
  • The trend backdrop is active with a 6-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • Activity pressure is weak, so confirmation is not yet broad enough.
  • 10 reversal markers appear in the recent smart-money tape.
  • Recent volatility is running well above the one-year baseline.
What to watch next
  • Price is close to its 52-week high; watch for continuation or exhaustion.
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 18.2% above the Trend Line and sits at 91.4% of its 52-week range. The latest completed week returned 6.2%, after a 16.7% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.7x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.4212-week average 0.35

12-week confirmation

Trend active10/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure4/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership4/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.42Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers1010 reversal markers

No recent accumulation markers. 10 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 16.7% over four weeks, 35.0% over 12 weeks, and 17.2% over one year. The current trend has remained active for 6 consecutive weeks.

Performance by holding period

1W6.2%
4W16.7%
12W35.0%
26W25.5%
52W17.2%
Active trend streak6 weeks
Active weeks in one year25
Trend breadth48.1%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.22Latest activity-pressure read.
Pressure change526.9%Four-week change in activity pressure.
Leadership9.08Latest relative-leadership reading.
RS change353.3%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 30 Apr 2026 Field coverage 88% Model confidence 86%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength12/100Blend of value, momentum, and quality. Underlying universe rank 89; rank 1 is best.
Value3/100Relative valuation strength. Underlying universe rank 98; rank 1 is best.
Quality13/100Profitability and accounting quality. Underlying universe rank 88; rank 1 is best.
Momentum82/100Medium-term price momentum. Underlying universe rank 19; rank 1 is best.
Growth17/100Revenue and earnings growth. Underlying universe rank 84; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework15/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
35.2x
Price divided by trailing earnings.
Price / sales
3.4x
Market value relative to trailing revenue.
EV / EBITDA
18.4x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-0.6%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
-
Gross profit retained from each unit of revenue.
Operating margin
14.8%
Operating profit retained from revenue.
Free-cash-flow margin
-2.3%
Free cash flow generated from revenue.
Return on invested capital
10.7%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
1.9%
Latest one-year revenue growth.
EPS growth
22.0%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-184.8%
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
1.3%
Cash dividends relative to market value.
Buyback yield
0.3%
Net share repurchases relative to market value.
Shareholder yield
1.6%
Dividend yield plus net buyback yield.
Net debt / EBITDA
1.4x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment55/100

Weighted news tone is neutral across 21 relevant articles.

5 positive · 16 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-2.6%Distance below the 52-week high.
13-week volatility8.0%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher12 of 2614 weeks finished lower.
Best week+20.1%Week of 3 Jul.
Worst week-8.9%Week of 5 Jun.
Latest week+6.2%Week of 7 Aug.

Shape of recent returns

Strong gains8
Modest gains4
Flat weeks0
Modest losses8
Sharp losses6
Recent vol8.0%13-week weekly-return volatility.
Base vol5.9%52-week weekly-return volatility.
Up/down split23/29Count of positive and negative weeks in the 52-week window.
Average skew5.3% / -3.4%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 2026627.0 GBP6.2%530.3 GBP426.4 GBP1.229.086.4MOn
31 Jul 2026590.5 GBP-1.0%527.4 GBP424.3 GBP0.893.004.1MOn
24 Jul 2026596.5 GBP7.1%523.5 GBP422.4 GBP0.685.149.9MOn
17 Jul 2026557.0 GBP3.6%519.4 GBP420.5 GBP0.04-0.712.8MOn
10 Jul 2026537.5 GBP-6.9%516.3 GBP418.7 GBP-0.28-3.595.1MOn
3 Jul 2026577.5 GBP20.1%514.2 GBP417.1 GBP-0.471.41810.2KOn
26 Jun 2026481.0 GBP-3.8%510.9 GBP415.2 GBP-0.80-14.451.3MOff
19 Jun 2026500.0 GBP-4.8%510.9 GBP414.0 GBP-0.54-10.392.6MOn
12 Jun 2026525.0 GBP5.0%510.6 GBP412.6 GBP-0.48-7.411.5MOn
5 Jun 2026500.0 GBP-8.9%510.3 GBP411.1 GBP-0.55-11.41746.6KOn
29 May 2026549.0 GBP4.3%511.7 GBP409.8 GBP-0.43-3.724.2MOn
22 May 2026526.5 GBP13.3%512.5 GBP408.0 GBP-0.40-8.243.6MOff
15 May 2026464.6 GBP-3.3%514.1 GBP406.3 GBP-0.12-16.907.1MOff
8 May 2026480.6 GBP-7.8%516.3 GBP405.1 GBP0.20-14.476.5MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context